Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Juno Genomics, |
RCV004796550 | SCV005416346 | uncertain significance | Atypical glycine encephalopathy | criteria provided, single submitter | clinical testing | PM2+PP3 | |
Ambry Genetics | RCV004968665 | SCV005510341 | uncertain significance | Inborn genetic diseases | 2024-11-24 | criteria provided, single submitter | clinical testing | The c.962C>T (p.T321M) alteration is located in exon 7 (coding exon 7) of the SLC6A9 gene. This alteration results from a C to T substitution at nucleotide position 962, causing the threonine (T) at amino acid position 321 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |